Company Filing History:
1 out of 4 
1 out of 4 
1 out of 832,891 Years Active: 2008
Title: Hugh-Chul Kim: Innovator in Immunotherapy
Introduction
Hugh-Chul Kim is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of immunotherapy through his innovative research and patents. His work focuses on the production of lymphoid dendritic cells, which play a crucial role in various therapeutic applications.
Latest Patents
Hugh-Chul Kim holds 1 patent related to his research. His patent describes a method for producing lymphoid dendritic cells with the immunophenotype CD8α. This method involves culturing human hematopoietic stem cells in a medium containing GM-CSF, followed by culturing in a medium containing IFN-α. The lymphoid dendritic cells produced through this method are valuable for various immunotherapies.
Career Highlights
Throughout his career, Hugh-Chul Kim has worked with several prominent companies in the biotechnology sector. He has been associated with Lifecord Inc. and Fcb-Pharmicell Co., Ltd., where he has contributed to advancing research in immunotherapy and cell production.
Collaborations
Hugh-Chul Kim has collaborated with notable colleagues, including Hyun-Soo Kim and Kyung-Bock Lee. Their joint efforts have furthered the understanding and application of dendritic cell therapies.
Conclusion
Hugh-Chul Kim's innovative work in the field of immunotherapy highlights his commitment to advancing medical science. His contributions through patents and collaborations continue to impact the development of effective treatments.